Methacrylic Acid

Methacrylic Acid

SCHEMBL316282

C=C(C)C(=O)O.C=CCOC(=O)C=C

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.44
HPGD P15428 2/20 0.42
ALDH1A1 P00352 6/20 0.42
TP53 P04637 4/20 0.42
HIF1A Q16665 3/20 0.42
CYP3A4 P08684 3/20 0.42
HSD17B10 Q99714 3/20 0.42
MAPT P10636 2/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 2/20 0.36
TDP1 Q9NUW8 1/20 0.35
APP P05067 1/20 0.35
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL459213 0.98 TSHR (0.42) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL14362184 0.98 TSHR (0.42) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL8664308 0.96 TSHR (0.41) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL8516311 0.96 TSHR (0.41) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL2641341 0.94 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL1172957 0.93 MAPT (0.45) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL1173477 0.93 MAPT (0.45) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL6275938 0.93 TSHR (0.39) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL3278000 0.93 TSHR (0.42) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL30200325 0.91 TSHR (0.44) TSHRHPGDALDH1A1TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 988 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111315318-B Light-responsive deformable polymer composition for colored optical lenses 纳亚姆创新私人有限公司 2023-04-25 CN claimed
EP-3266908-B1 ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME XEROX CORP (US) 2020-05-06 EP claimed
US-10570290-B2 Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins XEROX CORPORATION (US) 2020-02-25 US claimed
EP-3266613-B1 ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME XEROX CORP (US) 2019-10-16 EP claimed
US-10405540-B2 Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same XEROX CORPORATION (US) 2019-09-10 US claimed
US-10113059-B2 Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same XEROX CORPORATION (US) 2018-10-30 US claimed
US-10095140-B2 Styrene/acrylate and polyester resin particles XEROX CORPORATION (US) 2018-10-09 US claimed
US-10067434-B2 Emulsion aggregation toners XEROX CORPORATION (US) 2018-09-04 US claimed
US-10018931-B2 Toner compositions with optimized beta-carboxyethyl acrylate shell latex for improved particle formation and morphology XEROX CORPORATION (US) 2018-07-10 US claimed
US-10007200-B2 Antimicrobial toner XEROX CORPORATION (US) 2018-06-26 US claimed
US-5928829-A Latex processes XEROX CORPORATION (US) 1999-07-27 US claimed
US-5928832-A Toner adsorption processes XEROX CORPORATION (US) 1999-07-27 US claimed
EP-0928991-A2 Toner preparation processes Xerox Corporation (US) 1999-07-14 EP claimed
US-5869215-A Toner compositions and processes thereof XEROX CORPORATION (US) 1999-02-09 US claimed
US-5863698-A MIXING COLORANT COMPRISING PHOSPHATE-CONTAINING SURFACTANT, LATEX EMULSION, HEATING, STABILIZING XEROX CORPORATION (US) 1999-01-26 US claimed
US-5858601-A Toner processes XEROX CORPORATION (US) 1999-01-12 US claimed
US-5766818-A Toner processes with hydrolyzable surfactant XEROX CORPORATION (US) 1998-06-16 US claimed
US-5766817-A AGGREGATING COLORANT DISPERSION WITH LATEX MINIEMULSION CONTAINING POLYMER AND IONIC AND NONIONIC SURFACTANTS, COALESCING THE AGGREGATES GENERATED XEROX CORPORATION (US) 1998-06-16 US claimed
US-5763133-A Toner compositions and processes XEROX CORPORATION (US) 1998-06-09 US claimed
US-5747215-A Toner compositions and processes XEROX CORPORATION (US) 1998-05-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10113059-B2 Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same RPN1, RPN2, MSH2 TSHR 4205/4885HPGD 1695/4885ALDH1A1 2365/4885
US-10405540-B2 Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same TERB1, NBAS, MFAP1 TSHR 4098/4885HPGD 2095/4885ALDH1A1 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.